Literature DB >> 24121575

[Validation of BR23 questionnaire for the assessment of quality of life of breast cancer patients in Chile].

M Elisa Irarrázaval1, Pía F Rodríguez, Gerardo Fasce, Fernando W Silva, Herman Waintrub, Camilo Torres, Carolina Barriga, Marcela Fritis, Luis Marín.   

Abstract

BACKGROUND: Quality of Life assessment in oncologic patients evaluates the impact and sequels of the disease ana the adverse effects of available treatments. AIM: To validate in Chile the breast cancer specific-questionnaire (BR23) developed by the European Organization for Research and Treatment of Cancer (EORTC). PATIENTS AND METHODS: After performing a linguistic validation of the BR23 according to EORTC instructions, its psychometric properties were tested in 103 patients with breast cancer whose ages ranged from 34 to 83 years. Internal consistency of the scales was assessed using the Cronbach's alpha coefficient. The test-retest correlations of each scale (n = 83) were evaluated. The correlation of BR23 scales with SF36 version 2 and C30 version 3.0 scales was also assessed. The sensitivity and specificity of the instrument were analyzed using receiver operating characteristic curves (ROC).
RESULTS: Alpha values showed acceptable levels of internal consistency, ranging between 0.702 and 0.917 in all scales of BR23. The statistical analysis revealed significant test-retest correlations in most scales of BR23. The correlations between BR23 and similar domains of C30 and SF36 questionnaires were also significant. The BR23 questionnaire demonstrated satisfactory levels of sensitivity and specificity when compared with the SF-36 scale.
CONCLUSIONS: The BR23 questionnaire adapted for use in Chile is linguistically appropriate and psychometrically valid.

Entities:  

Mesh:

Year:  2013        PMID: 24121575     DOI: 10.4067/S0034-98872013000600006

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool.

Authors:  Stefano Maratia; Sergio Cedillo; Javier Rejas
Journal:  Qual Life Res       Date:  2016-04-05       Impact factor: 4.147

2.  Preliminary Study on the Effect of an Early Physical Therapy Intervention after Sentinel Lymph Node Biopsy: A Multicenter Non-Randomized Controlled Trial.

Authors:  María Jesús Muñoz-Fernández; Esther M Medrano-Sánchez; Beatriz Ostos-Díaz; Rocío Martín-Valero; Carmen Suárez-Serrano; María Jesús Casuso-Holgado
Journal:  Int J Environ Res Public Health       Date:  2021-01-31       Impact factor: 3.390

3.  Effect of Supervised Resistance Training on Arm Volume, Quality of Life and Physical Perfomance Among Women at High Risk for Breast Cancer-Related Lymphedema: A Study Protocol for a Randomized Controlled Trial (STRONG-B).

Authors:  Karol Ramírez-Parada; Maria Lopez-Garzon; Cesar Sanchez-Rojel; Militza Petric-Guajardo; Margarita Alfaro-Barra; Rodrigo Fernández-Verdejo; Alvaro Reyes-Ponce; Gina Merino-Pereira; Irene Cantarero-Villanueva
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  A randomized clinical trial to assess the effectiveness of pre- and post-surgical pelvic floor physiotherapy for bowel symptoms, pelvic floor function, and quality of life of patients with rectal cancer: CARRET protocol.

Authors:  Cinara Sacomori; Luz Alejandra Lorca; Mónica Martinez-Mardones; Roberto Ignacio Salas-Ocaranza; Guillermo Patricio Reyes-Reyes; Marta Natalia Pizarro-Hinojosa; Jorge Plasser-Troncoso
Journal:  Trials       Date:  2021-07-13       Impact factor: 2.279

5.  Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.

Authors:  Leslye Rojas-Concha; Maiken Bang Hansen; Morten Aagaard Petersen; Mogens Groenvold
Journal:  BMC Palliat Care       Date:  2020-06-09       Impact factor: 3.234

6.  Quality of life in women treated with chemotherapy for breast cancer in Cali, Colombia

Authors:  María Elena Mejía-Rojas; Adolfo Contreras-Rengifo; Mauricio Hernández-Carrillo
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.